U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 621 records

Showing results for "hour".

  1. Disposition of Comments_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertensive-disorders-pregnancy-disposition-comments.pdf
    May 31, 2023 - estimate a seizure risk of 9 per 1000 patients with preeclampsia with severe features treated with 24-hour … in comparative effectiveness trials, i.e., studies that compared shorter-duration regimens with 24-hour

  2. SAMHSA (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/goldstrom.pdf
    May 29, 2025 - SAMHSA INNOVATIONS CONFERENCE -- SAMHSA SPEAKER: INGRID GOLDSTROM, DIRECTOR OF THE EVALUATION OF CHILDREN’S MENTAL HEALTH INTIATIVE (CMHI) SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA) GOLDSTROM: So today I’ll be speaking about engaging mental health consu…

  3. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - Cyclosporine monitoring timepoints In adult renal transplants, how does two-hour post-administration … Cyclosporine monitoring timepoints • Intervention: o Two-hour post-administration monitoring of cyclosporine … strategy OR strategies OR regimen*)) 9 Cyclosporine monitoring timepoints ((‘2’ OR ‘two’) NEAR/1 hour

  4. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
    August 01, 2016 - acute kidney injury, including CIN: an increase in serum creatinine of at least 0.3 mg/dL over a 48-hour

  5. Facilitating a Deliberative Session: Transcript (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-transcript.pdf
    May 29, 2025 - We also want to leave at least a half hour at the end of the presentation for Q&A. … Deliberative methods span from a two hour session to a three day session. Alright. … Deliberative methods span from a two hour session to a three day session. … And Marge made the point that sometimes we can be facilitating for deliberation in a two hour session

  6. Alcohol-Misuse-Drug-Therapy Consumer (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
    February 01, 2016 - These effects can last for an hour or longer.

  7. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
    September 01, 2018 - informants from the Duke University Health System, a large academic health system, were scheduled for one-hour

  8. PHS 398 (Rev. 9/04), Continuation Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
    January 01, 2005 - PHS 398 (Rev. 9/04), Continuation Page Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1) Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data Principal Investigator: Brian L. Strom, MD, MPH Co-Principal Investigator: Sean Hennessy, PharmD…

  9. PHS 398 (Rev. 9/04), Continuation Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
    January 01, 2007 - PHS 398 (Rev. 9/04), Continuation Page Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1) Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data Principal Investigator: Brian L. Strom, MD, MPH Co-Principal Investigator: Sean Hennessy, PharmD…

  10. Masks-Appendix-Table-B-2-Surveillance-Report (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-2-surveillance-report.xlsx
    March 01, 2020 - B-2. Obs Studs Masks Community Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current. Appendix Table B-2. Observational Studies of Masks in the Community Virus Strain Author Publication Year Title Date Retrieved Source Link/URL Study Desig…

  11. Masks-Surveillance-2-Appendix-Table-A-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-2.xlsx
    March 01, 2020 - B-2. Obs Studs Masks Community Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current. Appendix Table A-2. Observational Studies of Masks in the Community Virus Strain Author Publication Year Title Date Retrieved Source Link/URL Study Desig…

  12. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - , gender, stage of chronification, severity of chronic pain, pain phenotype, pain duration, mean 24-hour

  13. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
    July 26, 2012 - treatments across a range of biochemistry levels (e.g. within several categories across a range of 24 hour … paragraph beginning on page 33 as follows: “Five trials based urine biochemistry measures on 24- hour … Patients with nephrolithiasis often undergo baseline metabolic work-up with 24 hour urine collections … Patients with nephrolithiasis often undergo baseline metabolic work-up with 24 hour urine collections

  14. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  15. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  16. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  17. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

  18. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - chain components  Quantitative  Sensitive only in concentrated urine (100x) to 30 mg/L  24-hour … chains 5.7–26.3 mg/L - κ/λ ratio 0.3–1.2  Mainstay of diagnosis for nonsecretory myeloma  24-hour

  19. Effects of Dietary Sodium and Potassium Intake on Chronic Disease (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
    April 18, 2017 - ratio) with validated measures or that use biomarker values to assess sodium level ((at least one 24-hour … sodium-to-potassium ratio) with validated measures or use biomarker values to assess sodium level (at least one 24-hour … ratio) with validated measures or use biomarkers values to assess potassium level (at least one 24-hour … ratio) with validated measures or use biomarkers values to assess potassium level (at least one 24-hour … validation or use of dietary intake measure only) and random error in sodium assessment (e.g., less than 24-hour

  20. Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Imaging Tests for the Staging of Colorectal Cancer Draft review available for public comment from October 24, 2013 to November 20, 2014 …
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites